Asia Pacific Clinical Nutrition Market 2022-2032 by Substrate, Administration Route (Oral or Enteral, Parenteral), Dosage Form (Powder, Liquid, Solid), Therapeutic Area, End User (Infant, Children, Adult, Geriatrics), Healthcare Setting, Distribution Channel, and Country: Trend Forecast and Growth Opportunity

December 2023 | 155 pages | ID: A254CD76B633EN
GMD Research

Abstracts

Asia Pacific clinical nutrition market will grow by 9.2% annually with a total addressable market cap of $328.51 billion over 2023-2032. The growth is driven by the increasing incidence of malnutrition, the rising prevalence of chronic diseases, the growing awareness pertaining to health and fitness among people, and the higher number of premature births.

Highlighted with 68 tables and 77 figures, this 155-page report “Asia Pacific Clinical Nutrition Market 2022-2032 by Substrate, Administration Route (Oral or Enteral, Parenteral), Dosage Form (Powder, Liquid, Solid), Therapeutic Area, End User (Infant, Children, Adult, Geriatrics), Healthcare Setting, Distribution Channel, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific clinical nutrition market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2020-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces

The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific clinical nutrition market in every aspect of the classification from perspectives of Substrate, Administration Route, Dosage Form, Therapeutic Area, End User, Healthcare Setting, Distribution Channel, and Country.

Based on Substrate, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Carbohydrates
• Lipids
• Proteins & Amino Acids
• Water & Electrolyte
• Dietary Fiber
• Antioxidants
• Other Substrates

Based on Administration Route, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Oral or Enteral Administration
• Oral Nutrition Supplements
• Tube Feeding
• Parenteral Administration
• Supplemental Parenteral Nutrition
• Total Parenteral Nutrition
• All-in-One System
• Multiple Bottle System

By Dosage Form, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Powder
• Liquid
• Solid and Semi-solid

By Therapeutic Area, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Malnutrition
• Metabolic Disorders
• Gastrointestinal Disorders
• Cancer
• Neurology
• Renal Diseases
• Respiratory Diseases
• Other Therapeutic Areas

By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Infant
• Children
• Adult
• Geriatrics

By Healthcare Setting, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Hospitals
• Long-term Care Facilities (LTC)
• Homecare
• Inpatient Rehabilitation Facilities
• Other Healthcare Settings

By Distribution Channel, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Institutional Sales
• Supermarkets & Hypermarkets
• Pharmacies
• Drug Stores
• Online Channels
• Other Distribution Channels

Geographically, the following national/local markets are fully investigated:

• Japan
• China
• South Korea
• Australia
• India
• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)

For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2032. The breakdown of national markets by Administration Route, Therapeutic Area, and End User over the forecast years are also included.

The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

Abbott Nutrition

B Braun Melsungen Ag

BASF SE

Baxter International Inc.

Claris Lifesciences Ltd.

Fresenius Kabi Ag

Lonza Group AG

Nestlй S.A.

Nutricia Ltd

Perrigo Company Plc

(Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)

Contents

1 INTRODUCTION

1.1 Industry Definition and Research Scope
  1.1.1 Industry Definition
  1.1.2 Research Scope
1.2 Research Methodology
  1.2.1 Overview of Market Research Methodology
  1.2.2 Market Assumption
  1.2.3 Secondary Data
  1.2.4 Primary Data
  1.2.5 Data Filtration and Model Design
  1.2.6 Market Size/Share Estimation
  1.2.7 Research Limitations
1.3 Executive Summary

2 MARKET OVERVIEW AND DYNAMICS

2.1 Market Size and Forecast
  2.1.1 Impact of COVID-19 on World Economy
  2.1.2 Impact of COVID-19 on the Market
  2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 SEGMENTATION OF ASIA PACIFIC MARKET BY SUBSTRATE

3.1 Market Overview by Substrate
3.2 Carbohydrates
3.3 Lipids
3.4 Proteins & Amino Acids
3.5 Water & Electrolyte
3.6 Dietary Fiber
3.7 Antioxidants
3.8 Other Substrates

4 SEGMENTATION OF ASIA PACIFIC MARKET BY ADMINISTRATION ROUTE

4.1 Market Overview by Administration Route
4.2 Oral or Enteral Administration
  4.2.1 Oral Nutrition Supplements
  4.2.2 Tube Feeding
4.3 Parenteral Administration
  4.3.1 Supplemental Parenteral Nutrition
  4.3.2 Total Parenteral Nutrition
  4.3.3 All-in-One System
  4.3.4 Multiple Bottle System

5 SEGMENTATION OF ASIA PACIFIC MARKET BY DOSAGE FORM

5.1 Market Overview by Dosage Form
5.2 Powder
5.3 Liquid
5.4 Solid and Semi-solid

6 SEGMENTATION OF ASIA PACIFIC MARKET BY THERAPEUTIC AREA

6.1 Market Overview by Therapeutic Area
6.2 Malnutrition
6.3 Metabolic Disorders
6.4 Gastrointestinal Disorders
6.5 Cancer
6.6 Neurology
6.7 Renal Diseases
6.8 Respiratory Diseases
6.9 Other Therapeutic Areas

7 SEGMENTATION OF ASIA PACIFIC MARKET BY END USER

7.1 Market Overview by End User
7.2 Infant
7.3 Children
7.4 Adult
7.5 Geriatrics

8 SEGMENTATION OF ASIA PACIFIC MARKET BY HEALTHCARE SETTING

8.1 Market Overview by Healthcare Setting
8.2 Hospitals
8.3 Long-term Care Facilities (LTC)
8.4 Homecare
8.5 Inpatient Rehabilitation Facilities
8.6 Other Healthcare Settings

9 SEGMENTATION OF ASIA PACIFIC MARKET BY DISTRIBUTION CHANNEL

9.1 Market Overview by Distribution Channel
9.2 Institutional Sales
9.3 Supermarkets & Hypermarkets
9.4 Pharmacies
9.5 Drug Stores
9.6 Online Channels
9.7 Other Distribution Channels

10 ASIA-PACIFIC MARKET 2022-2032 BY COUNTRY

10.1 Overview of Asia-Pacific Market
10.2 Japan
10.3 China
10.4 Australia
10.5 India
10.6 South Korea
10.7 Rest of APAC Region

11 COMPETITIVE LANDSCAPE

11.1 Overview of Key Vendors
11.2 New Product Launch, Partnership, Investment, and M&A
11.3 Company Profiles
Abbott Nutrition
B Braun Melsungen Ag
BASF SE
Baxter International Inc.
Claris Lifesciences Ltd.
Fresenius Kabi Ag
Lonza Group AG
Nestlй S.A.
Nutricia Ltd
Perrigo Company Plc
RELATED REPORTS

List Of Tables

LIST OF TABLES

Table 1. Snapshot of Asia Pacific Clinical Nutrition Market in Balanced Perspective, 2022-2032
Table 2. World Economic Outlook, 2021-2031
Table 3. World Economic Outlook, 2021-2023
Table 4. Scenarios for Economic Impact of Ukraine Crisis
Table 5. World Health Spending by Region, $ bn, 2013-2020
Table 6. Main Product Trends and Market Opportunities in Asia Pacific Clinical Nutrition Market
Table 7. Asia Pacific Clinical Nutrition Market by Substrate, 2022-2032, $ mn
Table 8. Asia Pacific Clinical Nutrition Market by Administration Route, 2022-2032, $ mn
Table 9. Asia Pacific Clinical Nutrition Market: Oral or Enteral Administration by Type, 2022-2032, $ mn
Table 10. Asia Pacific Clinical Nutrition Market: Parenteral Administration by Type, 2022-2032, $ mn
Table 11. Asia Pacific Clinical Nutrition Market by Dosage Form, 2022-2032, $ mn
Table 12. Asia Pacific Clinical Nutrition Market by Therapeutic Area, 2022-2032, $ mn
Table 13. Asia Pacific Clinical Nutrition Market by End User, 2022-2032, $ mn
Table 14. Asia Pacific Clinical Nutrition Market by Healthcare Setting, 2022-2032, $ mn
Table 15. Asia Pacific Clinical Nutrition Market by Distribution Channel, 2022-2032, $ mn
Table 16. APAC Clinical Nutrition Market by Country, 2022-2032, $ mn
Table 17. Japan Clinical Nutrition Market by Administration Route, 2022-2032, $ mn
Table 18. Japan Clinical Nutrition Market by Therapeutic Area, 2022-2032, $ mn
Table 19. Japan Clinical Nutrition Market by End User, 2022-2032, $ mn
Table 20. China Clinical Nutrition Market by Administration Route, 2022-2032, $ mn
Table 21. China Clinical Nutrition Market by Therapeutic Area, 2022-2032, $ mn
Table 22. China Clinical Nutrition Market by End User, 2022-2032, $ mn
Table 23. Australia Clinical Nutrition Market by Administration Route, 2022-2032, $ mn
Table 24. Australia Clinical Nutrition Market by Therapeutic Area, 2022-2032, $ mn
Table 25. Australia Clinical Nutrition Market by End User, 2022-2032, $ mn
Table 26. India Clinical Nutrition Market by Administration Route, 2022-2032, $ mn
Table 27. India Clinical Nutrition Market by Therapeutic Area, 2022-2032, $ mn
Table 28. India Clinical Nutrition Market by End User, 2022-2032, $ mn
Table 29. South Korea Clinical Nutrition Market by Administration Route, 2022-2032, $ mn
Table 30. South Korea Clinical Nutrition Market by Therapeutic Area, 2022-2032, $ mn
Table 31. South Korea Clinical Nutrition Market by End User, 2022-2032, $ mn
Table 32. Clinical Nutrition Market in Rest of APAC by Country/Region, 2022-2032, $ mn
Table 33. Abbott Nutrition: Company Snapshot
Table 34. Abbott Nutrition: Business Segmentation
Table 35. Abbott Nutrition: Product Portfolio
Table 36. B Braun Melsungen Ag: Company Snapshot
Table 37. B Braun Melsungen Ag: Business Segmentation
Table 38. B Braun Melsungen Ag: Revenue by Region
Table 39. B Braun Melsungen Ag: Product Portfolio
Table 40. BASF: Company Snapshot
Table 41. BASF: Business Segmentation
Table 42. BASF: Revenue by Region
Table 43. BASF: Product Portfolio
Table 44. Baxter International Inc.: Company Snapshot
Table 45. Baxter International Inc.: Business Segmentation
Table 46. Baxter International Inc.: Revenue by Region
Table 47. Baxter International Inc.: Product Portfolio
Table 48. Claris Lifesciences Ltd.: Company Snapshot
Table 49. Fresenius Kabi Ag: Company Snapshot
Table 50. Fresenius Kabi Ag: Business Segmentation
Table 51. Fresenius Kabi Ag: Revenue by Region
Table 52. Fresenius Kabi Ag: Product Portfolio
Table 53. Lonza Group: Company Snapshot
Table 54. Lonza Group: Business Segmentation in 2018
Table 55. Lonza Group: Product Portfolio
Table 56. Lonza Group: Revenue by Region in 2018
Table 57. Nestlй S.A.: Company Snapshot
Table 58. Nestlй S.A.: Business Segmentation
Table 59. Nestlй S.A.: Product Portfolio
Table 60. Nestlй S.A.: Revenue, 2018-2020, $ bn
Table 61. Nutricia Ltd: Company Snapshot
Table 62. Nutricia Ltd: Business Segmentation
Table 63. Nutricia Ltd: Revenue by Region
Table 64. Nutricia Ltd: Product Portfolio
Table 65. Perrigo Company Plc: Company Snapshot
Table 66. Perrigo Company Plc: Business Segmentation
Table 67. Perrigo Company Plc: Revenue by Region
Table 68. Perrigo Company Plc: Product Portfolio

List Of Figures

LIST OF FIGURES

Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2022-2032
Figure 4. Asia Pacific Clinical Nutrition Market, 2022-2032, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of Asia Pacific Clinical Nutrition Market
Figure 7. Leading Causes of Death in the World, 2000 and 2019, million
Figure 8. Worldwide Geriatric Population (60 years and above) by Region, 2015 & 2030, million
Figure 9. Forecast of World Middle-class Population by Region, 2015-2030, million
Figure 10. Primary Restraints and Impact Factors of Asia Pacific Clinical Nutrition Market
Figure 11. Investment Opportunity Analysis
Figure 12. Porter’s Fiver Forces Analysis of Asia Pacific Clinical Nutrition Market
Figure 13. Breakdown of Asia Pacific Clinical Nutrition Market by Substrate, 2022-2032, % of Revenue
Figure 14. Asia Pacific Addressable Market Cap in 2023-2032 by Substrate, Value ($ mn) and Share (%)
Figure 15. Asia Pacific Clinical Nutrition Market by Substrate: Carbohydrates, 2022-2032, $ mn
Figure 16. Asia Pacific Clinical Nutrition Market by Substrate: Lipids, 2022-2032, $ mn
Figure 17. Asia Pacific Clinical Nutrition Market by Substrate: Proteins & Amino Acids, 2022-2032, $ mn
Figure 18. Asia Pacific Clinical Nutrition Market by Substrate: Water & Electrolyte, 2022-2032, $ mn
Figure 19. Asia Pacific Clinical Nutrition Market by Substrate: Dietary Fiber, 2022-2032, $ mn
Figure 20. Asia Pacific Clinical Nutrition Market by Substrate: Antioxidants, 2022-2032, $ mn
Figure 21. Asia Pacific Clinical Nutrition Market by Substrate: Other Substrates, 2022-2032, $ mn
Figure 22. Breakdown of Asia Pacific Clinical Nutrition Market by Administration Route, 2022-2032, % of Sales Revenue
Figure 23. Asia Pacific Addressable Market Cap in 2023-2032 by Administration Route, Value ($ mn) and Share (%)
Figure 24. Asia Pacific Clinical Nutrition Market by Administration Route: Oral or Enteral Administration, 2022-2032, $ mn
Figure 25. Asia Pacific Clinical Nutrition Market by Oral or Enteral Administration: Oral Nutrition Supplements, 2022-2032, $ mn
Figure 26. Asia Pacific Clinical Nutrition Market by Oral or Enteral Administration: Tube Feeding, 2022-2032, $ mn
Figure 27. Asia Pacific Clinical Nutrition Market by Administration Route: Parenteral Administration, 2022-2032, $ mn
Figure 28. Asia Pacific Clinical Nutrition Market by Parenteral Administration: Supplemental Parenteral Nutrition, 2022-2032, $ mn
Figure 29. Asia Pacific Clinical Nutrition Market by Parenteral Administration: Total Parenteral Nutrition, 2022-2032, $ mn
Figure 30. Asia Pacific Clinical Nutrition Market by Parenteral Administration: All-in-One System, 2022-2032, $ mn
Figure 31. Asia Pacific Clinical Nutrition Market by Parenteral Administration: Multiple Bottle System, 2022-2032, $ mn
Figure 32. Breakdown of Asia Pacific Clinical Nutrition Market by Dosage Form, 2022-2032, % of Sales Revenue
Figure 33. Asia Pacific Addressable Market Cap in 2023-2032 by Dosage Form, Value ($ mn) and Share (%)
Figure 34. Asia Pacific Clinical Nutrition Market by Dosage Form: Powder, 2022-2032, $ mn
Figure 35. Asia Pacific Clinical Nutrition Market by Dosage Form: Liquid, 2022-2032, $ mn
Figure 36. Asia Pacific Clinical Nutrition Market by Dosage Form: Solid and Semi-solid, 2022-2032, $ mn
Figure 37. Breakdown of Asia Pacific Clinical Nutrition Market by Therapeutic Area, 2022-2032, % of Revenue
Figure 38. Asia Pacific Addressable Market Cap in 2023-2032 by Therapeutic Area, Value ($ mn) and Share (%)
Figure 39. Asia Pacific Clinical Nutrition Market by Therapeutic Area: Malnutrition, 2022-2032, $ mn
Figure 40. Asia Pacific Clinical Nutrition Market by Therapeutic Area: Metabolic Disorders, 2022-2032, $ mn
Figure 41. Asia Pacific Clinical Nutrition Market by Therapeutic Area: Gastrointestinal Disorders, 2022-2032, $ mn
Figure 42. Asia Pacific Clinical Nutrition Market by Therapeutic Area: Cancer, 2022-2032, $ mn
Figure 43. Asia Pacific Clinical Nutrition Market by Therapeutic Area: Neurology, 2022-2032, $ mn
Figure 44. Asia Pacific Clinical Nutrition Market by Therapeutic Area: Renal Diseases, 2022-2032, $ mn
Figure 45. Asia Pacific Clinical Nutrition Market by Therapeutic Area: Respiratory Diseases, 2022-2032, $ mn
Figure 46. Asia Pacific Clinical Nutrition Market by Therapeutic Area: Other Therapeutic Areas, 2022-2032, $ mn
Figure 47. Breakdown of Asia Pacific Clinical Nutrition Market by End User, 2022-2032, % of Revenue
Figure 48. Asia Pacific Addressable Market Cap in 2023-2032 by End User, Value ($ mn) and Share (%)
Figure 49. Asia Pacific Clinical Nutrition Market by End User: Infant, 2022-2032, $ mn
Figure 50. Asia Pacific Clinical Nutrition Market by End User: Children, 2022-2032, $ mn
Figure 51. Asia Pacific Clinical Nutrition Market by End User: Adult, 2022-2032, $ mn
Figure 52. Asia Pacific Clinical Nutrition Market by End User: Geriatrics, 2022-2032, $ mn
Figure 53. Breakdown of Asia Pacific Clinical Nutrition Market by Healthcare Setting, 2022-2032, % of Revenue
Figure 54. Asia Pacific Addressable Market Cap in 2023-2032 by Healthcare Setting, Value ($ mn) and Share (%)
Figure 55. Asia Pacific Clinical Nutrition Market by Healthcare Setting: Hospitals, 2022-2032, $ mn
Figure 56. Asia Pacific Clinical Nutrition Market by Healthcare Setting: Long-term Care Facilities (LTC), 2022-2032, $ mn
Figure 57. Asia Pacific Clinical Nutrition Market by Healthcare Setting: Homecare, 2022-2032, $ mn
Figure 58. Asia Pacific Clinical Nutrition Market by Healthcare Setting: Inpatient Rehabilitation Facilities, 2022-2032, $ mn
Figure 59. Asia Pacific Clinical Nutrition Market by Healthcare Setting: Other Healthcare Settings, 2022-2032, $ mn
Figure 60. Breakdown of Asia Pacific Clinical Nutrition Market by Distribution Channel, 2022-2032, % of Revenue
Figure 61. Asia Pacific Addressable Market Cap in 2023-2032 by Distribution Channel, Value ($ mn) and Share (%)
Figure 62. Asia Pacific Clinical Nutrition Market by Distribution Channel: Institutional Sales, 2022-2032, $ mn
Figure 63. Asia Pacific Clinical Nutrition Market by Distribution Channel: Supermarkets & Hypermarkets, 2022-2032, $ mn
Figure 64. Asia Pacific Clinical Nutrition Market by Distribution Channel: Pharmacies, 2022-2032, $ mn
Figure 65. Asia Pacific Clinical Nutrition Market by Distribution Channel: Drug Stores, 2022-2032, $ mn
Figure 66. Asia Pacific Clinical Nutrition Market by Distribution Channel: Online Channels, 2022-2032, $ mn
Figure 67. Asia Pacific Clinical Nutrition Market by Distribution Channel: Other Distribution Channels, 2022-2032, $ mn
Figure 68. Breakdown of APAC Clinical Nutrition Market by Country, 2022 and 2032, % of Revenue
Figure 69. Contribution to APAC 2023-2032 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 70. Clinical Nutrition Market in Japan, 2022-2032, $ mn
Figure 71. Clinical Nutrition Market in China, 2022-2032, $ mn
Figure 72. Clinical Nutrition Market in Australia, 2022-2032, $ mn
Figure 73. Clinical Nutrition Market in India, 2022-2032, $ mn
Figure 74. Clinical Nutrition Market in South Korea, 2022-2032, $ mn
Figure 75. Clinical Nutrition Market in Rest of APAC, 2022-2032, $ mn
Figure 76. Growth Stage of Asia Pacific Clinical Nutrition Industry over the Forecast Period
Figure 77. Nestlй S.A.: Revenue by Region, 2018